Syncom Formulations Fixes Record Date for 10% Dividend, Schedules 38th AGM for Sep 30
Syncom Formulations has set September 23, 2026, as the record date for a 10% dividend for FY26. The 38th AGM, where the dividend requires approval, is scheduled for September 30, 2026, conducted via VC/OAVM. Shareholders can waive dividends by September 26, 2026.
The announcement is of medium impact as it pertains to dividend declaration and AGM schedule, which are standard corporate events. While positive for shareholders, it does not represent a significant strategic shift or major financial performance update.
The announcement is positive as it confirms the record date for dividend payment and the schedule for the Annual General Meeting, indicating routine corporate operations and potential returns to shareholders.
Syncom Formulations (India) Limited has announced the 'Record Date' as Wednesday, 23rd September 2026, for determining member entitlement to a 10% dividend (₹0.10 per equity share) for the financial year 2025-26. This dividend is subject to approval at the company's 38th Annual General Meeting (AGM).
Shareholders wishing to voluntarily waive their dividend entitlement must submit a duly filled Dividend Waiver Form by 26th September 2026, via email to finance@sfil.in or RTA at investor@ankitonline.com / compliance@ankitonline.com. The Dividend Waiver Form is available on the company's website, www.syncomformulations.com.
Furthermore, the 38th AGM of the company is scheduled to be held on Wednesday, 30th September 2026, at 2:00 P.M. through Video Conferencing (VC)/Other Audio-Visual Means (OAVM).
What to do with a filing like this
Syncom Formulations (India) Limited filed this with the NSE as a statutory disclosure, categorised under dividend. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Syncom Formulations (India) Limited. Read the original for the full detail.